Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 13/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | USP14 | P54578 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20156141 | 0.94 | TDP2 (0.36) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20114697 | 0.93 | ALDH1A1 (0.38) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20114657 | 0.93 | ALDH1A1 (0.38) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20156214 | 0.93 | ALDH1A1 (0.37) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20155976 | 0.92 | ALDH1A1 (0.37) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20150424 | 0.91 | TDP2 (0.37) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20114645 | 0.90 | GRM2 (0.38) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20156184 | 0.90 | ALDH1A1 (0.38) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20155945 | 0.89 | ALDH1A1 (0.40) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 | |
| SCHEMBL20114715 | 0.89 | ALDH1A1 (0.37) | ALDH1A1HPGDLMNAMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-09-24 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | ALDH1A1 387/4885HPGD 2446/4885LMNA 3586/4885 |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, EPCAM, F12 | ALDH1A1 387/4885HPGD 2446/4885LMNA 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.